Hand Dermatitis Clinical Trials

A listing of Hand Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 116 clinical trials
featured
Atopic Dermatitis or Eczema

This study is to see how safe and effective the topical spray on trial medication is when used on subjects with Pruritus or Itch with Atopic Dermatitis. 

topical agents
  • 0 views
  • 29 Jul, 2021
  • 1 location
Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable

Primary Objective: To demonstrate the efficacy of dupilumab on itch response in patients with prurigo nodularis (PN), inadequately controlled on topical prescription therapy or when those therapies are not advisable Secondary Objectives: To demonstrate the efficacy of dupilumab on additional itch endpoints in patients with PN, inadequately controlled on topical …

  • 41 views
  • 15 Jun, 2021
  • 66 locations
Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted Scoring

Inflammatory skin disorders are usually assessed by disease scoring system such as Scoring AD (SCORAD)/Eczema Area and Severity Index (EASI) and Psoriasis Area and Severity Index (PASI) for atopic eczema and psoriasis respectively. The current approach to score the severity of these inflammatory skin disorders is through clinical observations and …

  • 0 views
  • 29 Mar, 2021
  • 1 location
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatitis.

topical agents
topical corticosteroid
ly3009104
baricitinib
atopy
  • 103 views
  • 31 Jul, 2021
  • 190 locations
Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

This is a research study to determine the efficacy and safety of investigational drug MEDI3506 for the treatment of adult subjects with Atopic Dermatitis.

topical agents
body mass index
atopy
  • 182 views
  • 27 Jul, 2021
  • 58 locations
Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis

The purpose of the study is to compare the efficacy and safety of benralizumab versus placebo and to compare benralizumab dosing regimens during extension period.

topical agents
follicle stimulating hormone
hysterectomy
  • 0 views
  • 15 Jul, 2021
  • 62 locations
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This 110-week study is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis.

topical agents
hormonal contraception
progestogen
lebrikizumab
atopy
  • 154 views
  • 26 Jul, 2021
  • 347 locations
Study To Assess Efficacy Safety Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

This study is being conducted to provide data on efficacy, safety, tolerability and PK of PF-07038124 ointment versus vehicle control in the treatment of mild to moderate AD and mild to moderate plaque psoriasis.

psoriasis
  • 0 views
  • 22 Jun, 2021
  • 36 locations
Seal Stopping Eczema and Allergy Study

This is a randomized, controlled trial designed for children who are have already developed atopic dermatitis (AD or eczema) by 10 weeks of age. The aim is to compare the effect of proactive sequential skin care, including the twice-daily use of a tri-lipid skin barrier cream (Epiceram) or moisturizer and …

topical agents
dry skin
epiceram
eczema
food allergy
  • 0 views
  • 19 Jul, 2021
  • 3 locations
Deployment o the Multidisciplinary Prospective Cohort Imminent

Immune-mediated inflammatory diseases (IMIDs) most often affect young patients and have high impact on morbidity and mortality with a significant alteration in the quality of life of patients with professional, social and emotional repercussions. Beyond this burden, IMIDs share many common pathophysiological mechanisms and treatments, known as "targeted therapies". Despite …

disease or disorder
  • 0 views
  • 24 May, 2021
  • 1 location